Group One Trading’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
FBIL
Group One Trading's LEGN Position: Q1 2026 in Review
Group One Trading increased its Legend Biotech (LEGN) stake by 27% in Q1 2026, buying an estimated $208K and bringing the position to 50,910 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #2802.
Group One Trading first reported a position in LEGN in Q1 2022 and has held it in 13 quarters since. The position peaked at $2.1M in Q3 2024. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.
- Group One Trading held 50,910 shares of Legend Biotech worth $921K as of Q1 2026.
- Group One Trading bought 10,934 Legend Biotech shares in Q1 2026, an estimated $208K.
- Legend Biotech made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2802 holding.
- Group One Trading first reported a position in Legend Biotech in Q1 2022 and has held it in 13 quarters since.
- Group One Trading's Legend Biotech position peaked at $2.1M in Q3 2024.
- 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.